Jeffrey Harris
Corporate Officer/Principal bei University of California San Diego
Aktive Positionen von Jeffrey Harris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of California San Diego | Corporate Officer/Principal | 07.09.2009 | - |
Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum | Corporate Officer/Principal | 07.09.2009 | - |
Karriereverlauf von Jeffrey Harris
Ehemalige bekannte Positionen von Jeffrey Harris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
American Otological Society, Inc. | Präsident | - | - |
The Association for Research in Otolaryngology | Präsident | - | - |
OTONOMY | Direktor/Vorstandsmitglied | 07.09.2009 | - |
Gründer | 01.04.2008 | - |
Ausbildung von Jeffrey Harris
University of Pennsylvania | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
President | 2 |
Director/Board Member | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
American Otological Society, Inc. | |
The Association for Research in Otolaryngology | |
Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum |
- Börse
- Insiders
- Jeffrey Harris
- Erfahrung